Clinical trial
Radiofrequency Ablation of Lung Tumors
NCT00180856 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed
Key facts
| NCT number | NCT00180856 |
|---|---|
| Title | Radiofrequency Ablation of Lung Tumors |
| Official title | A Phase II Study of Radiofrequency Ablation of Lung Tumors |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Metastasis |
| Intervention type | Procedure |
| Interventions | Radiofrequency ablation |
| Enrollment | 60 |
| Start date | Jan 1, 2002 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: